EPS Bio Technology Corp. announced earnings results for the second quarter ended June 30, 2021. For the second quarter, the company announced total revenue was TWD 119.411 million compared to TWD 142.993 million a year ago. Operating income was TWD 10.626 million compared to TWD 19.308 million a year ago. Net income was TWD 6.464 million compared to TWD 13.979 million a year ago. Basic earnings per share was TWD 0.27 compared to TWD 0.59 a year ago. For the half year, total revenue was TWD 207.891 million compared to TWD 250.039 million a year ago. Operating income was TWD 7.227 million compared to TWD 24.430 million a year ago. Net income was TWD 1.114 million compared to TWD 18.265 million a year ago. Basic earnings per share was TWD 0.05 compared to TWD 0.77 a year ago. Diluted earnings per share was TWD 0.05 compared to TWD 0.76 a year ago.